Condition: Bone Angioma · Sponsor: Centre Hospitalier Universitaire de Saint Etienne
The investigators aimed to evaluate efficacy and safety of a non-surgical protocol treatment combining transarterial embolization and percutaneous radiopaque gelled ethanol (RGE) sclerotherapy in a first procedure, then followed by vertebroplasty in a second procedure, to treat aggressive vertebral hemangioma patients in tertiary hospital. Exclusion criteria were age \<18-years old and any association with neurological deficit.
This description comes directly from the study's public registry record.
Sylvain GRANGE, MD · (0)477829066 · sylvain.grange@chu-st-étienne.fr
Always discuss trial participation with your own doctor first.
| CHU de Saint-Etienne | Saint-Priest-en-Jarez, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06607731